The Inspire ANTI SNORING Implant is a medical device that is implanted in to the body for the treating snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive anti snoring syndrome is a disease caused by relapsing episodes of sleep apnea. It is a condition where breathing stops for more than 10 seconds, during which oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs during sleep, when the muscles of upper airways relax, causing the obstruction of the respiratory tract. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places stress on the body, causing increased blood circulation pressure and development of severe diseases. The diseases due to OSA can be physical, such as hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severe nature of the condition. The apnea index is considered significant if you can find more than 20 apnea episodes each hour, whatever the presence or lack of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many people find it uncomfortable to sleep with the mask on the facial skin and the device itself can be loud, especially as it commonly sits close to the head. Only 25% of patients may use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire ANTI SNORING Implant.
How The Inspire ANTI SNORING Implant Works
The Inspire ANTI SNORING Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of the device is placed beneath the skin, on leading right side of the chest and it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens the upper airways and allows the tongue to stick out, and helps keep the airways open while asleep.
In addition to the two electrodes, this product also contains a handy small remote switch, that actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating through the active phase of the day, when a person needs physiological narrowing of the larynx and tongue movements for these procedures.
The individual may feel light involuntary contractions of the larynx, or tongue movements during initial use of the device. These movements usually do not cause pain, instead just a minor discomfort. These unpleasant effects disappear after the first few uses of these devices.
Generally, the implant should be checked 1 or 2 2 times per year. However, according to the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire ANTI SNORING Implant is only ideal for:
Patients who are a lot more than 22 years old.
Patients who’ve been diagnosed with moderate or severe obstructive sleep apnea syndrome.
Patients with an apnea index in the range of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or didn’t work.
Patients with a body mass index of significantly less than 32.
ufabet Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire ANTI SNORING Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A study by Dr. Ryan J. et al. shows that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at two years following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly usage of this therapy for five years. Therefore, it is evident that method is highly effective and easy to use!
